While standard monitoring visits focus primarily on source document verification, protocol deviations, drug inventory, recruiting, and enrollment issues, SEEVs go beyond traditional monitoring and into the specifics of endpoint collection, ensuring that every detail is standardized and controlled at each clinical site. The outcome is results with integrity, data with low variability and decreased placebo response creating a decisive development path. SEEVs provide detailed review of the data collection methods, procedures, and equipment. Clinical site staff perform mock procedures with specially trained CPC team members to ensure consistent elements in collecting the critical data, methodologies, attitudes, and practices of the site staff.

CPC Clinical Research has developed innovative endpoint core labs in many different areas (e.g., Treadmill Testing, 6-Minute Walk, Pulmonary Function Testing (PFT), Wound Assessment, and more). Our endpoint core labs provide central and standardized solutions for reviewing data collection methods, evaluating data quality, and providing expert data interpretation.

The SQuAd Committee convenes frequently and allows quick and consistent problem solving to the unique endpoint issues that inevitably arise during trials. This committee includes Dr. William Hiatt, other clinical scientists, CPC project KOLs, Project Managers, and the CRAs who are doing the hands-on review of the endpoint data. This committee provides thoughtful solutions for consistent correction of site errors producing a higher degree of endpoint data quality.

As the experts in reducing variability in endpoint data collection, CPC can enhance your team’s knowledge of both the disease under study and how to ensure it is measured accurately. In conjunction with our other EQuIP services, our hands-on training programs provide your project team, when that team involves non-CPC staff, with tools and information that allow them to help identify problems early in the trial. We work collaboratively with your team to ensure you have the best quality data possible at the conclusion of your trial. In addition to our endpoint and disease specific training, CPC has developed a series of general clinical trials training courses for newly-hired clinical staff that need to be immediately productive.

To ensure an unbiased evaluation and verification of the analysis, it is optimal to have clinical trial results reviewed by an independent, academic research organization. CPC provides the independent, third-party review for your trial results. These independent analyses are often required by the major journals for publication.

Publication is important to your trial and important to CPC. One of our initiatives is to make information from EQuIP available to the public in the form of publications.